Cardiogenic Pulmonary Edema in Emergency Medicine

Area of Science:

• Cardiology
• Pulmonology
• Critical Care Medicine

Background:

• Cardiogenic pulmonary edema (CPE) is acute respiratory failure from lung alveolar fluid accumulation.
• Elevated left heart pressures from cardiac diseases cause CPE, leading to increased capillary pressure and barrier disruption.
• Factors like inflammation, leukocyte infiltration, and mechanical stretch contribute to alveolar-epithelial barrier breakdown.

Purpose of the Study:

• To review the pathophysiology, clinical presentation, and management of cardiogenic pulmonary edema.
• To highlight the importance of identifying specific CPE phenotypes for tailored therapy.

Main Methods:

• Review of existing literature on cardiogenic pulmonary edema.
• Analysis of diagnostic approaches including medical history, physical examination, pulmonary ultrasound, natriuretic peptide levels, chest radiography, and echocardiography.
• Discussion of therapeutic strategies such as non-invasive ventilation, diuretics, vasodilators, inotropes, vasopressors, beta-agonists, and pentoxifylline.

Main Results:

• CPE pathophysiology involves elevated cardiac filling pressures, barrier disruption, and inflammation.
• Diagnostic evaluation requires a comprehensive approach combining clinical assessment and imaging/biomarker tests.
• Management strategies are tailored to the underlying cause and patient's clinical status, including respiratory support and pharmacological interventions.

Conclusions:

• Prompt identification and management of CPE are crucial for improving patient outcomes.
• Non-invasive ventilation (NIV) should be considered early in CPE treatment.
• Personalized therapeutic approaches based on CPE phenotype are essential for effective disease management.